Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England

Abstract Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2006 and the 13-valent pneumococcal conjugate vaccine (PCV13) in 2010 in the UK. PCVs are active immunization for the prevention of invasive disease, pneumonia and acute otitis media (AOM) caused by Streptococcu...

Full description

Bibliographic Details
Main Authors: Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Thomas Weiss, Ian Matthews, Eric Sarpong, Ignacio Méndez, Nawab Qizilbash
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-023-14982-8
_version_ 1811171521330151424
author Salini Mohanty
Bélène Podmore
Ana Cuñado Moral
Thomas Weiss
Ian Matthews
Eric Sarpong
Ignacio Méndez
Nawab Qizilbash
author_facet Salini Mohanty
Bélène Podmore
Ana Cuñado Moral
Thomas Weiss
Ian Matthews
Eric Sarpong
Ignacio Méndez
Nawab Qizilbash
author_sort Salini Mohanty
collection DOAJ
description Abstract Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2006 and the 13-valent pneumococcal conjugate vaccine (PCV13) in 2010 in the UK. PCVs are active immunization for the prevention of invasive disease, pneumonia and acute otitis media (AOM) caused by Streptococcus pneumoniae in children. The aim of this observational study was to estimate incidence rates (IRs) of AOM in children ≤17 years from 2003 to 2019 in England, before and after the introduction of pneumococcal conjugate vaccines (PCVs). Methods AOM episodes were identified using Read diagnosis codes in children aged ≤17 years in the Clinical Practice Research Datalink (CPRD) Gold database from 2003 to 2019. Annual IRs with 95% confidence intervals (CI) by age group were calculated as the number of episodes/person-years (PY) at risk. Interrupted time series analyses were conducted to estimate incidence rate ratios (IRR) across post-PCV7 (2007–2009), early post-PCV13 (2011–2014) and late post-PCV13 (2015–2019) periods compared to the pre-PCV7 period (2003–2005) using generalized linear models. Results From 2003 to 2019, 274,008 all-cause AOM episodes were identified in 1,500,686 children. The overall AOM IR was 3690.9 (95% CI 3677.1-3704.8) per 100,000 PY. AOM IRs were highest in children aged < 5 years and decreased by age; < 2 years: 8286.7 (95% CI 8216.8-8357.1); 2–4 years: 7951.8 (95% CI 7902.5-8001.4); 5–17 years: 2184.4 (95% CI 2172.1–2196.8) (per 100,000 PY). Overall AOM IRs declined by 40.3% between the pre-PCV7 period and the late-PCV13 period from 4451.9 (95% CI 4418.1-4485.9) to 2658.5 (95% CI 2628.6-2688.7) per 100,000 PY, and across all age groups. IRRs indicated a significant decrease in AOM IRs in all the post-vaccination periods, compared to the pre-PCV7 period: post-PCV7 0.87 (95% CI 0.85–0.89), early post-PCV13 0.88 (95% CI 0.86–0.91), and late post-PCV13 0.75 (95% CI 0.73–0.78). Conclusions The AOM IRs declined during the 2003–2019 period; however, the clinical burden of AOM remains substantial among children ≤17 years in England.
first_indexed 2024-04-10T17:15:23Z
format Article
id doaj.art-a501e19a36a445c7a1eadd47c92f3fcf
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-04-10T17:15:23Z
publishDate 2023-01-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-a501e19a36a445c7a1eadd47c92f3fcf2023-02-05T12:26:21ZengBMCBMC Public Health1471-24582023-01-0123111110.1186/s12889-023-14982-8Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in EnglandSalini Mohanty0Bélène Podmore1Ana Cuñado Moral2Thomas Weiss3Ian Matthews4Eric Sarpong5Ignacio Méndez6Nawab Qizilbash7Merck & Co., Inc, Center for Observational and Real-World Evidence (CORE)OXON Epidemiology Ltd, Epidemiology & StatisticsOXON Epidemiology Ltd, Epidemiology & StatisticsMerck & Co., Inc, Center for Observational and Real-World Evidence (CORE)MSD (UK) Ltd, Value, Access and Devolved nations (VAD)Merck & Co., Inc., Real-world Data Analytics and Innovation (RDAI)OXON Epidemiology Ltd, Epidemiology & StatisticsOXON Epidemiology Ltd, Epidemiology & StatisticsAbstract Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2006 and the 13-valent pneumococcal conjugate vaccine (PCV13) in 2010 in the UK. PCVs are active immunization for the prevention of invasive disease, pneumonia and acute otitis media (AOM) caused by Streptococcus pneumoniae in children. The aim of this observational study was to estimate incidence rates (IRs) of AOM in children ≤17 years from 2003 to 2019 in England, before and after the introduction of pneumococcal conjugate vaccines (PCVs). Methods AOM episodes were identified using Read diagnosis codes in children aged ≤17 years in the Clinical Practice Research Datalink (CPRD) Gold database from 2003 to 2019. Annual IRs with 95% confidence intervals (CI) by age group were calculated as the number of episodes/person-years (PY) at risk. Interrupted time series analyses were conducted to estimate incidence rate ratios (IRR) across post-PCV7 (2007–2009), early post-PCV13 (2011–2014) and late post-PCV13 (2015–2019) periods compared to the pre-PCV7 period (2003–2005) using generalized linear models. Results From 2003 to 2019, 274,008 all-cause AOM episodes were identified in 1,500,686 children. The overall AOM IR was 3690.9 (95% CI 3677.1-3704.8) per 100,000 PY. AOM IRs were highest in children aged < 5 years and decreased by age; < 2 years: 8286.7 (95% CI 8216.8-8357.1); 2–4 years: 7951.8 (95% CI 7902.5-8001.4); 5–17 years: 2184.4 (95% CI 2172.1–2196.8) (per 100,000 PY). Overall AOM IRs declined by 40.3% between the pre-PCV7 period and the late-PCV13 period from 4451.9 (95% CI 4418.1-4485.9) to 2658.5 (95% CI 2628.6-2688.7) per 100,000 PY, and across all age groups. IRRs indicated a significant decrease in AOM IRs in all the post-vaccination periods, compared to the pre-PCV7 period: post-PCV7 0.87 (95% CI 0.85–0.89), early post-PCV13 0.88 (95% CI 0.86–0.91), and late post-PCV13 0.75 (95% CI 0.73–0.78). Conclusions The AOM IRs declined during the 2003–2019 period; however, the clinical burden of AOM remains substantial among children ≤17 years in England.https://doi.org/10.1186/s12889-023-14982-8Acute otitis mediaRecurrent AOMPneumococcal conjugate vaccineUnited Kingdom
spellingShingle Salini Mohanty
Bélène Podmore
Ana Cuñado Moral
Thomas Weiss
Ian Matthews
Eric Sarpong
Ignacio Méndez
Nawab Qizilbash
Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England
BMC Public Health
Acute otitis media
Recurrent AOM
Pneumococcal conjugate vaccine
United Kingdom
title Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England
title_full Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England
title_fullStr Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England
title_full_unstemmed Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England
title_short Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England
title_sort incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in england
topic Acute otitis media
Recurrent AOM
Pneumococcal conjugate vaccine
United Kingdom
url https://doi.org/10.1186/s12889-023-14982-8
work_keys_str_mv AT salinimohanty incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland
AT belenepodmore incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland
AT anacunadomoral incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland
AT thomasweiss incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland
AT ianmatthews incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland
AT ericsarpong incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland
AT ignaciomendez incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland
AT nawabqizilbash incidenceofacuteotitismediafrom2003to2019inchildren17yearsinengland